Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Business Strategies & IT
Eyes on the Prize
Karen Gotting-Smith tells NGP how AstraZeneca stays fighting fit in difficult times.
DNA Sequence Assembly and Analysis – It’s a Whole New World!
Next generation DNA sequencing instruments, introduced to the market in the past few years, are beginning to dominate the landscape of DNA sequencing projects – and rightfully so.
Outsourcing Asset Management
Bob Moore of GE Healthcare examines the benefits of contracting out scientific asset services.
Collaboration in Pharmaceutical Industry
Collaboration is more than just working together on shared documents. Collaboration is a fundamental aspect of the business that is present throughout the modern pharmaceutical organization. As companies transition to more distributed operations, and
Optimize Revenue Generation Engine through Performance Management
The life sciences industry continues to be challenged by the competing demands of regulatory drivers, distribution requirements and changing patient demographics.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.